TLPHTalphera, Inc.
0.8071USD+0.87%Mkt Cap: 41.26M USDP/E: Last update: 2026-06-01

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized fo…

Indicators:|

Key Statistics

Company
Market Cap41.26M USD
Enterprise Value27.74M USD
Revenue (TTM)1.00K USD
Gross Profit-245.00K USD
Net Income (TTM)-14.29M USD
Revenue/Share0.0000 USD
Last Price0.8071 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees12
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-3.26
PEG
EV/EBITDA
EV/Revenue27735.92
P/S42350.11
P/B2.37
EPS (TTM)-0.28
EPS (Forward)-0.25
52W Range
0.380036% of range1.570
52W High1.570 USD
52W Low0.3800 USD
Profitability
Gross Margin0.00%
Oper. Margin-1451600.00%
EBITDA Margin0.00%
Profit Margin-51035.71%
ROE-83.89%
ROA-48.08%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-11.36M USD
CapEx (TTM)
FCF Margin-577750.00%
FCF Yield-14.00%
Net Debt-14.61M USD
Net Debt/EBITDA
Balance Sheet
Debt/Equity35.17
Current Ratio5.30
Quick Ratio5.24
Book Value/Sh0.3450 USD
Cash/Share0.4070 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:20
Split DateOct 26, 2022
Analyst Consensus
Rating
Target (Mean)3.250 USD
Target Range3.000 USD3.500 USD
# Analysts2
Ownership
Shares Out.51.90M
Float26.75M
Insiders24.24%
Institutions34.76%
Short Interest
Short Ratio6.7d
Short % Float2.23%
Short % Out.1.80%
Shares Short936.33K
Short (prev mo.)1.23M
Technical
SMA 500.8130 (-0.7%)
SMA 2000.9505 (-15.1%)
Beta
S&P 52W Chg27.70%
Avg Vol (30d)137.42K
Avg Vol (10d)130.70K
Technical Indicators
RSI (14)44.8
MACD-0.0072
MACD Signal0.0013
MACD Hist.-0.0084
BB Upper0.9359 USD
BB Middle0.8517 USD
BB Lower0.7675 USD
BB Width19.77%
ATR (14)0.0619 USD
Vol Ratio (20d)1.22x